Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, FloridaLearn More President and CEO Alessandro Maselli Presents the 2025 Endpoints 11 Awards — Watch Celebration of Biotech’s Brightest.Learn More Catalent Welcomes UK Secretary of State for Transport to Swindon SiteLearn More Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical ResearchLearn More Catalent Expert Discusses the Nuances, and Promise, of Cell Therapy Projects in Post-BIO 2025 InterviewLearn More How can we work together ORAL BIOLOGICS CELL & GENE THERAPY CLINICAL SUPPLY CONSUMER Latest News Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, Florida ORAL MANUFACTURING With our innovative technologies, experience in tech transfers and product launches, and exceptional quality standards, Catalent can support your program with reliable supply to global markets. LEARN MORE WINCHESTER SITE TOUR With over 30 years of expertise, the Winchester, KY site offers large scale manufacturing for complex controlled-release oral dose forms, with fully integrated analytical and development services. EXPLORE NOW HPAPI SOLUTIONS Catalent is your global CDMO partner offering comprehensive integrated solutions that enable flexibility on the journey of bringing your highly potent product from development to commercialization. DISCOVER MORE Watch on YouTube GLOBAL NETWORK With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs. SEE ALL LOCATIONS JOIN OUR TEAM Catalent is growing & hiring! Join the global drug development and delivery leader that puts “Patient First” at the center of our work every day. Learn more about careers at Catalent. NEWS Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, Florida Catalent Announces New Board Appointments Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S. Novo Holdings Completes Acquisition of Catalent VIEW ALL NEW EVENTS Meeting on the Mesa A3P Congress NLS Days 2025 GCSG European Knowledge Forum 2025 VIEW ALL EVENTS EXPERT CONTENT Fast-Track Clinical Transition from Lipid-based Solution to Lipid-based Suspension in Softgels From IV to Oral: Leveraging Softgel to Extend Vinorelbine’s Lifecycle & Improve Patient Convenience Spray Drying for Inhaled Drugs: Minimize Risk, Maximize Yield Fast, Flexible, Bioavailable: Lipid-Based Softgels for BCS I–IV VIEW ALL ARTICLES